GSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...

A Europol report on criminal networks released in April said the majority of Europe's most dangerous gangs now focused on drug smuggling, mainly dealing in cocaine, cannabis, heroin and synthetic ...

As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss pharma’s top-selling drug Entresto. In a court decision filed this ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

The recent approvals of Sanofi/Regeneron’s Dupixent for COPD (from the European Medicines Agency/EMA in July 2024 and the US Food and Drug Administration/FDA in September 2024) and the ...

So cautious and moderate was former immigration minister Robert Jenrick when he entered the Commons that he was nicknamed “Robert Generic”. Yet now 10 years later, he has reached the final two ...

Vaccines are an essential part of global efforts to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens.

Oct 9 (Reuters) - The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be available for no more than $2 for a month's supply ...